Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) traded down 23.3% during mid-day trading on Saturday . The stock traded as low as C$0.12 and last traded at C$0.12. 1,797,794 shares changed hands during mid-day trading, an increase of 540% from the average session volume of 280,948 shares. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Stock Down 23.3 %
The firm’s 50-day simple moving average is C$0.10 and its 200 day simple moving average is C$0.13. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28. The stock has a market capitalization of C$18.65 million, a P/E ratio of -3.55 and a beta of 0.39.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Breakout Stocks: What They Are and How to Identify Them
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Why Are These Companies Considered Blue Chips?
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
